Negara: Irlandia
Bahasa: Inggris
Sumber: HPRA (Health Products Regulatory Authority)
PHENOXYMETHYLPENICILLIN
Morningside Healthcare Limited
J01CE02
PHENOXYMETHYLPENICILLIN
250 Milligram
Film Coated Tablet
Product subject to prescription which may not be renewed (A)
phenoxymethylpenicillin
Not Marketed
2011-04-01
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Phenoxymethylpenicillin 250mg Film-coated Tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains phenoxymethylpenicillin 250 mg (as phenoxymethylpenicillin potassium). For a full list of excipients, see section 6.1 3 PHARMACEUTICAL FORM Film-coated tablet White, circular, biconvex film coated tablets with break line on one side and ‘I 04’ on the other. The tablet can be divided into equal halves 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Phenoxymethylpenicillin is indicated in the treatment or prophylaxis of mild to moderately severe infections caused by penicillin sensitive organisms, i.e. those microorganisms whose susceptibility to phenoxymethylpenicillin is within the range of serum levels attained. Phenoxymethylpenicillin is indicated for the treatment of the following infections (See Section 5.1) Streptococcal infections: Pharyngitis Scarlet fever Skin and soft tissue infections (e.g. erysipelas) Pneumococcal infections: Pneumonia Otitis media Vincent's gingivitis and pharyngitis Phenoxymethylpenicillin is also indicated for (see Section 5.1): Prophylaxis of rheumatic fever and/or chorea Prophylaxis of pneumococcal infection (e.g. in asplenia and in patients with sickle cell disease) Consideration should be given to official guidance on the appropriate use of antibacterial agents. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Phenoxymethylpenicillin 250 mg is approximately equivalent to 400,000 units. Each tablet should be swallowed whole with water, at least 30 minutes before food, as ingestion of phenoxymethylpenicillin with meals slightly reduces the absorption of the drug. I R I S H M E D I C I N E S B O A R D ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ Baca dokumen lengkapnya